By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antiasthmatic combinations > Airsupra (inhalation) > Albuterol / Budesonide Dosage
Antiasthmatic combinations
https://themeditary.com/dosage-information/albuterol-budesonide-dosage-4765.html

Albuterol / Budesonide Dosage

Drug Detail:Airsupra (inhalation) (Albuterol and budesonide (inhalation) [ al-byoo-ter-ole-and-byoo-des-oh-nide ])

Drug Class: Antiasthmatic combinations

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Asthma

Albuterol 180 mcg-budesonide 160 mcg oral inhalation as needed
(Administered as 2 actuations of this product)

Maximum dose: 6 doses (12 inhalations) a day

Comments:

  • This product delivers a combination of albuterol (90 mcg) and budesonide (80 mcg) with a single actuation.
  • Prime the product prior to using it for the first time to ensure appropriate product content in each actuation.
  • To prime this product, release 4 sprays into the air away from the face, shaking well before each spray.
  • When used in geriatric patients with concomitant cardiovascular disease, use with caution.
  • Shake well before using.

Use: For the treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in adult patients with asthma.

Renal Dose Adjustments

Caution is recommended when administering high doses of this product to patients with renal impairment.

Liver Dose Adjustments

Dose adjustment may be required. However, no specific guidelines have been suggested.

Precautions

CONTRAINDICATIONS:
Hypersensitivity to the active component or any of the ingredients

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For oral inhalation use only.
  • Avoid using or storing near heat or an open flame.
  • Reprime the inhaler after cleaning or if it is not used for more than seven days, or if it is dropped.
  • To re-prime this product, release 2 sprays into the air away from the face, shaking well before each spray.

Storage requirements:
  • Store at 20C to 25C (68F to 77F); excursions are permitted to 15C to 30C (59F to 86F).
  • Store in a dry place away from heat and sunlight.

General:
  • Exposure to temperatures above 49C (120F) may cause bursting.
  • Do not put the canister in a fire or incinerator. Avoid getting spray in your eyes.

Monitoring:
RENAL: Monitor renal function in geriatric patients.

Patient advice:
  • Read the US FDA-approved patient labeling (Medication Guide).
  • Watch out for the number of inhalations remaining in the canister using a dose indicator attached to the canister when nearing the end of the usable inhalations.
  • Discard this product when the pointer reaches zero or 12 months after removal of the foil pouch, whichever comes first.
  • Do not immerse the canister in water to determine the amount remaining in the canister ("float test").
  • Shake well before using.
  • Seek medical attention immediately if treatment with this product becomes less effective or symptoms worsen.
  • Discontinue treatment with this product and contact healthcare provider if paradoxical bronchospasm develops.
  • The recommended dose should not be exceeded.
  • If hypersensitivity reactions occur, contact the healthcare provider and discontinue use of this product.
  • Avoid exposure to chickenpox or measles during treatment with immunosuppressive doses of corticosteroids and, if exposed, consult the physician immediately due to the risk of new or worsening infections.
  • Rinse mouth with water, if available, after each inhalation to help reduce the risk of thrush.
  • This product may cause systemic corticosteroid effects such as hypercorticism and adrenal suppression.
  • This product may also increase the risk of bone mineral density loss.
  • Long-term use of this product may increase the risk of increased intraocular pressure, glaucoma, and cataracts; therefore, consider regular eye examinations.
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by